TUBA3D
gene geneOn this page
Also known as H2-ALPHA
Summary
TUBA3D (tubulin alpha 3d, HGNC:24071) is a protein-coding gene on chromosome 2q21.1, encoding Tubulin alpha-3D chain (P0DPH8). Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. It is a selective cancer dependency (DepMap: 16.4% of cell lines).
This gene encodes a member of the alpha tubulin family. Tubulin is a major component of microtubules, which are composed of alpha- and beta-tubulin heterodimers and microtubule-associated proteins in the cytoskeleton. Microtubules maintain cellular structure, function in intracellular transport, and play a role in spindle formation during mitosis.
Source: NCBI Gene 113457 — RefSeq curated summary.
At a glance
- Gene–disease (curated): keratoconus 9 (Limited, GenCC)
- Clinical variants (ClinVar): 3 total
- Phenotypes (HPO): 5
- Cancer dependency (DepMap): dependent in 16.4% of screened cell lines
- MANE Select transcript:
NM_080386
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24071 |
| Approved symbol | TUBA3D |
| Name | tubulin alpha 3d |
| Location | 2q21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | H2-ALPHA |
| Ensembl gene | ENSG00000075886 |
| Ensembl biotype | protein_coding |
| OMIM | 617878 |
| Entrez | 113457 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000321253, ENST00000409047
RefSeq mRNA: 1 — MANE Select: NM_080386
NM_080386
CCDS: CCDS33290
Canonical transcript exons
ENST00000321253 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001957482 | 131476119 | 131476202 |
| ENSE00002481699 | 131482552 | 131482934 |
| ENSE00002489437 | 131478164 | 131478386 |
| ENSE00002526860 | 131480069 | 131480749 |
| ENSE00003555115 | 131479308 | 131479456 |
Expression profiles
Bgee: expression breadth ubiquitous, 130 present calls, max score 99.02.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3667 / max 360.8680, expressed in 5 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 22549 | 0.3250 | 5 |
| 202393 | 0.0418 | 3 |
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 99.02 | gold quality |
| left testis | UBERON:0004533 | 98.82 | gold quality |
| testis | UBERON:0000473 | 98.09 | gold quality |
| heart left ventricle | UBERON:0002084 | 93.07 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 89.39 | gold quality |
| apex of heart | UBERON:0002098 | 88.38 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.02 | gold quality |
| heart | UBERON:0000948 | 81.68 | gold quality |
| fallopian tube | UBERON:0003889 | 76.27 | gold quality |
| right atrium auricular region | UBERON:0006631 | 75.52 | gold quality |
| left uterine tube | UBERON:0001303 | 73.74 | gold quality |
| right uterine tube | UBERON:0001302 | 70.62 | gold quality |
| prostate gland | UBERON:0002367 | 70.36 | gold quality |
| body of uterus | UBERON:0009853 | 70.03 | gold quality |
| endocervix | UBERON:0000458 | 69.31 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 66.46 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 65.82 | gold quality |
| cerebellum | UBERON:0002037 | 65.76 | gold quality |
| cerebellar cortex | UBERON:0002129 | 65.75 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 65.35 | gold quality |
| stromal cell of endometrium | CL:0002255 | 65.15 | gold quality |
| myometrium | UBERON:0001296 | 65.05 | gold quality |
| uterine cervix | UBERON:0000002 | 64.56 | gold quality |
| left ovary | UBERON:0002119 | 63.70 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 63.60 | gold quality |
| right ovary | UBERON:0002118 | 62.84 | gold quality |
| ovary | UBERON:0000992 | 62.68 | gold quality |
| ectocervix | UBERON:0012249 | 62.51 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 62.28 | gold quality |
| lymph node | UBERON:0000029 | 62.16 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 1175.93 |
| E-GEOD-124263 | yes | 808.09 |
| E-ANND-3 | yes | 11.32 |
Regulation
Is transcription factor: no
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 16.4% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 1)
- TUBA3D is a new gene that causes keratoconus.The c.31 C > T (Gln11stop) and c.201insTT (Val68Leufs*2) mutations lead to TUBA3D degradation and higher matrix metalloproteinases expression in cornea fibroblasts. (PMID:29051577)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tuba7l | ENSDARG00000104643 |
| rattus_norvegicus | Tuba3a | ENSRNOG00000031707 |
| drosophila_melanogaster | alphaTub84B | FBGN0003884 |
| drosophila_melanogaster | alphaTub84D | FBGN0003885 |
Paralogs (23): TUBG2 (ENSG00000037042), TUBE1 (ENSG00000074935), TUBB1 (ENSG00000101162), TUBB4A (ENSG00000104833), TUBD1 (ENSG00000108423), TUBA1B (ENSG00000123416), TUBA4A (ENSG00000127824), TUBG1 (ENSG00000131462), TUBB2A (ENSG00000137267), TUBB2B (ENSG00000137285), TUBA3E (ENSG00000152086), TUBA1A (ENSG00000167552), TUBA1C (ENSG00000167553), TUBB8B (ENSG00000173213), TUBB6 (ENSG00000176014), TUBAL3 (ENSG00000178462), TUBA8 (ENSG00000183785), TUBB4B (ENSG00000188229), TUBB (ENSG00000196230), TUBA3C (ENSG00000198033), TUBA4B (ENSG00000243910), TUBB3 (ENSG00000258947), TUBB8 (ENSG00000261456)
Protein
Protein identifiers
Tubulin alpha-3D chain — P0DPH8 (reviewed: P0DPH8)
Alternative names: Alpha-tubulin 3D
All UniProt accessions (2): P0DPH8, Q1ZYQ1
UniProt curated annotations — full annotation on UniProt →
Function. Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin.
Subunit / interactions. Dimer of alpha and beta chains. A typical microtubule is a hollow water-filled tube with an outer diameter of 25 nm and an inner diameter of 15 nM. Alpha-beta heterodimers associate head-to-tail to form protofilaments running lengthwise along the microtubule wall with the beta-tubulin subunit facing the microtubule plus end conferring a structural polarity. Microtubules usually have 13 protofilaments but different protofilament numbers can be found in some organisms and specialized cells.
Subcellular location. Cytoplasm. Cytoskeleton.
Tissue specificity. Expressed in the cornea, sclera, and peripheral blood.
Post-translational modifications. Some glutamate residues at the C-terminus are polyglutamylated, resulting in polyglutamate chains on the gamma-carboxyl group. Polyglutamylation plays a key role in microtubule severing by spastin (SPAST). SPAST preferentially recognizes and acts on microtubules decorated with short polyglutamate tails: severing activity by SPAST increases as the number of glutamates per tubulin rises from one to eight, but decreases beyond this glutamylation threshold. Glutamylation is also involved in cilia motility. Some glutamate residues at the C-terminus are monoglycylated but not polyglycylated due to the absence of functional TTLL10 in human. Monoglycylation is mainly limited to tubulin incorporated into cilia and flagella axonemes, which is required for their stability and maintenance. Flagella glycylation controls sperm motility. Both polyglutamylation and monoglycylation can coexist on the same protein on adjacent residues, and lowering glycylation levels increases polyglutamylation, and reciprocally. Acetylation of alpha chains at Lys-40 is located inside the microtubule lumen. This modification has been correlated with increased microtubule stability, intracellular transport and ciliary assembly. Methylation of alpha chains at Lys-40 is found in mitotic microtubules and is required for normal mitosis and cytokinesis contributing to genomic stability. Nitration of Tyr-450 is irreversible and interferes with normal dynein intracellular distribution. Undergoes a tyrosination/detyrosination cycle, the cyclic removal and re-addition of a C-terminal tyrosine residue by the enzymes tubulin tyrosine carboxypeptidase (MATCAP1/KIAA0895L, VASH1 or VASH2) and tubulin tyrosine ligase (TTL), respectively. Tyrosination promotes microtubule interaction with CAP-Gly domain-containing proteins such as CLIP1, CLIP2 and DCTN1. Tyrosination regulates the initiation of dynein-dynactin motility via interaction with DCTN1, which brings the dynein-dynactin complex into contact with microtubules. In neurons, tyrosinated tubulins mediate the initiation of retrograde vesicle transport. Detyrosination is involved in metaphase plate congression by guiding chromosomes during mitosis: detyrosination promotes interaction with CENPE, promoting pole-proximal transport of chromosomes toward the equator. Detyrosination increases microtubules-dependent mechanotransduction in dystrophic cardiac and skeletal muscle. In cardiomyocytes, detyrosinated microtubules are required to resist to contractile compression during contraction: detyrosination promotes association with desmin (DES) at force-generating sarcomeres, leading to buckled microtubules and mechanical resistance to contraction.
Disease relevance. Keratoconus 9 (KTCN9) [MIM:617928] An autosomal dominant form of keratoconus, a common degenerative corneal disease characterized by progressive, non-inflammatory thinning of the corneal stroma, corneal ectasia, and cone-shaped corneal protrusion that results in reduced vision. The disease is caused by variants affecting the gene represented in this entry.
Domain organisation. The MREC motif may be critical for tubulin autoregulation.
Similarity. Belongs to the tubulin family.
RefSeq proteins (1): NP_525125* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000217 | Tubulin | Family |
| IPR002452 | Alpha_tubulin | Family |
| IPR003008 | Tubulin_FtsZ_GTPase | Domain |
| IPR008280 | Tub_FtsZ_C | Homologous_superfamily |
| IPR017975 | Tubulin_CS | Conserved_site |
| IPR018316 | Tubulin/FtsZ_2-layer-sand-dom | Domain |
| IPR023123 | Tubulin_C | Homologous_superfamily |
| IPR036525 | Tubulin/FtsZ_GTPase_sf | Homologous_superfamily |
| IPR037103 | Tubulin/FtsZ-like_C | Homologous_superfamily |
Pfam: PF00091, PF03953
Catalyzed reactions (Rhea), 1 shown:
- GTP + H2O = GDP + phosphate + H(+) (RHEA:19669)
UniProt features (20 total): binding site 9, modified residue 4, chain 2, site 1, sequence variant 1, sequence conflict 1, short sequence motif 1, active site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DPH8-F1 | 91.57 | 0.82 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (2): 450 (involved in polymerization); 254
Ligand- & substrate-binding residues (9): 179; 206; 228; 11; 71; 71; 140; 144; 145
Post-translational modifications (4): 40, 282, 439, 450
Function
Pathways and Gene Ontology
Reactome pathways
86 pathways
| ID | Pathway |
|---|---|
| R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane |
| R-HSA-190840 | Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane |
| R-HSA-190861 | Gap junction assembly |
| R-HSA-2132295 | MHC class II antigen presentation |
| R-HSA-2467813 | Separation of Sister Chromatids |
| R-HSA-2500257 | Resolution of Sister Chromatid Cohesion |
| R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand |
| R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes |
| R-HSA-389957 | Prefoldin mediated transfer of substrate to CCT/TriC |
| R-HSA-389960 | Formation of tubulin folding intermediates by CCT/TriC |
| R-HSA-389977 | Post-chaperonin tubulin folding pathway |
| R-HSA-437239 | Recycling pathway of L1 |
| R-HSA-5610787 | Hedgehog ‘off’ state |
| R-HSA-5620920 | Cargo trafficking to the periciliary membrane |
| R-HSA-5620924 | Intraflagellar transport |
| R-HSA-5626467 | RHO GTPases activate IQGAPs |
| R-HSA-5663220 | RHO GTPases Activate Formins |
| R-HSA-6807878 | COPI-mediated anterograde transport |
| R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic |
| R-HSA-6811436 | COPI-independent Golgi-to-ER retrograde traffic |
| R-HSA-68877 | Mitotic Prometaphase |
| R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint |
| R-HSA-8955332 | Carboxyterminal post-translational modifications of tubulin |
| R-HSA-9609690 | HCMV Early Events |
| R-HSA-9609736 | Assembly and cell surface presentation of NMDA receptors |
| R-HSA-9619483 | Activation of AMPK downstream of NMDARs |
| R-HSA-9646399 | Aggrephagy |
| R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation |
| R-HSA-9668328 | Sealing of the nuclear envelope (NE) by ESCRT-III |
| R-HSA-983189 | Kinesins |
MSigDB gene sets: 163 (showing top):
REACTOME_ADAPTIVE_IMMUNE_SYSTEM, REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM, REACTOME_MEMBRANE_TRAFFICKING, PATIL_LIVER_CANCER, UEDA_PERIFERAL_CLOCK, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6, SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN, GOBP_MITOTIC_CELL_CYCLE, REACTOME_GAP_JUNCTION_ASSEMBLY, REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES, IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM, GOCC_CILIUM, TOMIDA_METASTASIS_UP, GOMF_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON
GO Biological Process (4): microtubule cytoskeleton organization (GO:0000226), mitotic cell cycle (GO:0000278), cytoskeleton organization (GO:0007010), microtubule-based process (GO:0007017)
GO Molecular Function (5): structural constituent of cytoskeleton (GO:0005200), GTP binding (GO:0005525), hydrolase activity (GO:0016787), metal ion binding (GO:0046872), nucleotide binding (GO:0000166)
GO Cellular Component (5): cytoplasm (GO:0005737), microtubule (GO:0005874), cilium (GO:0005929), microtubule cytoskeleton (GO:0015630), cytoskeleton (GO:0005856)
Reactome top-level categories
Rollup of top-15 pathways:
| Category | Pathways |
|---|---|
| Mitotic Prometaphase | 2 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 2 |
| Assembly of the 9+0 primary cilium | 2 |
| RHO GTPase Effectors | 2 |
| Golgi-to-ER retrograde transport | 2 |
| Membrane Trafficking | 1 |
| Transport of connexons to the plasma membrane | 1 |
| Gap junction trafficking | 1 |
| Adaptive Immune System | 1 |
| Mitotic Anaphase | 1 |
| Cellular responses to stress | 1 |
| Protein folding | 1 |
| L1CAM interactions | 1 |
| Signaling by Hedgehog | 1 |
| ER to Golgi Anterograde Transport | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoskeleton organization | 2 |
| cytoskeleton | 2 |
| microtubule-based process | 1 |
| cell cycle | 1 |
| mitotic nuclear division | 1 |
| organelle organization | 1 |
| cellular process | 1 |
| structural molecule activity | 1 |
| guanyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| catalytic activity | 1 |
| cation binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| microtubule cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A5A6J1, P02550, P02552, P05213, P05214, P06603, P06604, P06605, P08537, P09644, P0DPH7, P0DPH8, P18258, P18288, P30436, P34690, P36220, P41383, P52273, P68360, P68361, P68362, P68363, P68365, P68366, P68367, P68368, P68369, P68370, P68373, P81947, P81948, Q06331, Q28IX8, Q2HJ86, Q2XVP4, Q32KN8, Q3ZCJ7, Q4R538, Q52PV9
Diamond homologs: A0AAL4, A5A6J1, B9DGT7, B9DHQ0, O22347, O22348, O22349, P02550, P02552, P04105, P04106, P05213, P05214, P06603, P06604, P08537, P09204, P09205, P09243, P0DPH7, P0DPH8, P10872, P10873, P11139, P11237, P11480, P11481, P12543, P14640, P14641, P14642, P18258, P18288, P22275, P28268, P28287, P28752, P29511, P30436, P32255
SIGNOR signaling
3 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| “Elongator complex” | “up-regulates activity” | TUBA3D | acetylation |
| TUBA3D | up-regulates | Neuron_migration | |
| ATAT1 | “up-regulates quantity by stabilization” | TUBA3D | acetylation |
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
816 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:131478155:T:TA | acceptor_gain | 1.0000 |
| 2:131478160:A:AG | acceptor_gain | 1.0000 |
| 2:131478161:C:G | acceptor_gain | 1.0000 |
| 2:131478162:A:AG | acceptor_gain | 1.0000 |
| 2:131478162:A:C | acceptor_loss | 1.0000 |
| 2:131478162:AGC:A | acceptor_gain | 1.0000 |
| 2:131478162:AGCGC:A | acceptor_gain | 1.0000 |
| 2:131478163:G:GA | acceptor_gain | 1.0000 |
| 2:131478163:GC:G | acceptor_gain | 1.0000 |
| 2:131478163:GCG:G | acceptor_gain | 1.0000 |
| 2:131478163:GCGC:G | acceptor_gain | 1.0000 |
| 2:131478163:GCGCG:G | acceptor_gain | 1.0000 |
| 2:131478337:C:T | donor_gain | 1.0000 |
| 2:131478383:GTCG:G | donor_gain | 1.0000 |
| 2:131478386:GGTA:G | donor_loss | 1.0000 |
| 2:131478387:G:GG | donor_gain | 1.0000 |
| 2:131478387:GTAG:G | donor_loss | 1.0000 |
| 2:131478388:T:G | donor_loss | 1.0000 |
| 2:131479303:T:A | acceptor_gain | 1.0000 |
| 2:131479306:A:AG | acceptor_gain | 1.0000 |
| 2:131479306:A:G | acceptor_loss | 1.0000 |
| 2:131479306:AGAT:A | acceptor_gain | 1.0000 |
| 2:131479307:G:GT | acceptor_gain | 1.0000 |
| 2:131479307:GA:G | acceptor_gain | 1.0000 |
| 2:131479307:GAT:G | acceptor_gain | 1.0000 |
| 2:131479307:GATG:G | acceptor_gain | 1.0000 |
| 2:131479307:GATGA:G | acceptor_gain | 1.0000 |
| 2:131479452:AACTG:A | donor_gain | 1.0000 |
| 2:131479453:ACTG:A | donor_gain | 1.0000 |
| 2:131479454:CTG:C | donor_gain | 1.0000 |
AlphaMissense
2955 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1001305595 (2:131477504 C>G), RS1002819666 (2:131477999 T>C), RS1002902032 (2:131475038 G>A), RS1002974080 (2:131474709 C>A,G), RS1003667640 (2:131479714 C>A,T), RS1003773994 (2:131479033 T>C), RS1004723294 (2:131479906 G>A,C), RS1004823708 (2:131475343 T>G), RS1005397689 (2:131483102 T>C), RS1005421286 (2:131476278 T>C), RS1005677070 (2:131476533 A>G), RS1005843301 (2:131481284 T>A), RS1007068686 (2:131483206 T>C), RS1007186242 (2:131477220 T>C), RS1007214433 (2:131482415 G>A)
Disease associations
OMIM: gene MIM:617878 | disease phenotypes: MIM:617928
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| keratoconus 9 | Limited | Unknown |
Mondo (1): keratoconus 9 (MONDO:0054771)
Orphanet (0):
HPO phenotypes
5 total (5 of 5 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000006 | Autosomal dominant inheritance |
| HP:0000563 | Keratoconus |
| HP:0003621 | Juvenile onset |
| HP:0007663 | Reduced visual acuity |
| HP:0100689 | Decreased corneal thickness |
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Estradiol | affects binding, increases expression, affects expression, increases reaction | 2 |
| aristolochic acid I | decreases expression | 1 |
| methyleugenol | decreases expression | 1 |
| sulforaphane | affects binding | 1 |
| cupric chloride | decreases expression | 1 |
| cupric oxide | decreases expression | 1 |
| phenethyl isothiocyanate | affects binding | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| bromovanin | increases expression | 1 |
| Zoledronic Acid | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Atrazine | increases expression | 1 |
| Calcitriol | increases expression, affects cotreatment | 1 |
| Cocaine | decreases expression | 1 |
| Demecolcine | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Dihydrotestosterone | increases expression | 1 |
| Testosterone | affects cotreatment, increases expression | 1 |
| Vincristine | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: keratoconus 9
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): keratoconus 9